Scientific Abstracts should contain new, scientifically rigorous information that has not been published previously. ESO encourages simultaneous presentation of scientific results at the conference and publication of research findings in major journals. Presenters of major clinical trials or other major studies should please discuss their presentation and publication plans with the Abstract Committee well in advance so as to optimise the presentation and publication opportunities.
Clinical Trial definition:
A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions (such as novel drugs, specific devices, behavioural therapy etc.) on health-related biomedical or behavioural outcomes).
When submitting a clinical trial, please always indicate the trial registration number (e.g. clinicaltrials.gov NO).
Ongoing trials topic:
Is only for proposed posters that will describe the design and/or progress of an ongoing trial – i.e. trials that will have not closed in time to present results at ESOC 2023.
Studies excluding clinical trials:
Is for all studies which do NOT qualify as clinical trial as defined above.
Late-breaking science:
Results of clinical trials or high impact large studies that will only be complete after this deadline (but in time to release results in a late-breaking session) can be submitted to the late breaking science section. It is important to mention why the submitted science is of high impact.
Further information on the abstract submission timeline will follow soon.
If you anticipate submitting your final results as a late-breaking contribution, you are encouraged to submit a placeholder abstract now (deadline 17 January 2023) to the regular system. This abstract can describe the trial/large study and the analyses that will be available. This will assist the conference committee in reserving a suitable slot on the programme and you can update your abstract with results during the late breaking submission window.
In order to standardise the abstract layout, we kindly ask you to read the guidelines carefully.
Young stroke physicians and researchers:
The main aim is to support young stroke researchers in promoting their research project under construction to the wider stroke community and to have their proposed study design reviewed in an open forum and by an expert mentor in the field. We hope that this will help young researchers to refine their study design and to promote collaboration with other groups and centres.
As in previous years, young investigators (<35 years) are invited to submit an abstract for the workshop describing a planned research study, an ongoing project still under development or interim results from an ongoing project.
The abstracts should be submitted to a special category (4.28: “YSPR design workshop for studies in development”).
The successful applicants will give an oral presentation, followed by constructive assessment of the study’s design and advice on its future development by a senior, internationally-renowned invited investigator. In addition to providing expert guidance on the development of the study, the workshop will be an opportunity for the young researchers to promote their work to the wider community and establish collaborations.
The presenters of the two top scoring abstracts will receive a place at the ESO Summer School or the ESO Edinburgh Stroke Winter School in 2023.
All presenters will be interviewed by other Young Stroke Physicians and Researchers and the interviews will be featured on the ESO blog (https://eso-stroke.org/news/).
Questions? If you have questions regarding abstracts, technical questions or need assistance, please contact the abstract team at abstracts@congrex.com. When contacting the abstract team please always refer to the name of the conference.
Abstract hotline: +41 61 686 77 63 (Monday – Friday during CET business hours)